专利检索 ap:("EpicentRx, Inc.") AND inv:"Jan SCICINSKI" 第 1 页

1.

发明公开
COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE 审中-公开

公开(公告)号：US20230233524A1

公开(公告)日：2023-07-27

申请号：US18083922

申请日：2022-12-19

申请人： EpicentRx, Inc.

发明人： Bryan T. ORONSKY , Jan SCICINSKI , Scott CAROEN

IPC分类号： A61K31/397 , A61P35/02 , A61P35/00 , A61K9/00 , A61K31/194 , A61K31/727 , A61K35/14 , A61K47/10 , A61K47/18

CPC分类号： A61K31/397 , A61P35/02 , A61P35/00 , A61K9/0019 , A61K31/194 , A61K31/727 , A61K35/14 , A61K47/10 , A61K47/18 , A61K47/46

摘要： The invention provides compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone (ABDNAZ), including formulations containing, autologous whole blood and ABDNAZ that can be rapidly administered to a patient by intravenous infusion without any significant pain at the site of infusion.